Birgitte Volck
Director/Board Member presso SOLENO THERAPEUTICS, INC.
Patrimonio netto: 301 526 $ in data 31/03/2024
Profilo
Attualmente, Birgitte Volck ricopre la posizione di SVP, Head-Clinical Development & Medical Affairs presso Ascendis Pharma A. La dottoressa Volck è anche nel consiglio di Soleno Therapeutics, Inc. e Vaccibody AS. La dottoressa Volck ha precedentemente occupato la posizione di Head-Research & Development presso GlaxoSmithKline Plc, Chief Medical Officer & Senior VP-Development presso Swedish Orphan Biovitrum AB, President-Research & Development presso Avrobio, Inc, Director-Executive Development presso Amgen, Inc, Director-Nordic Medical & Project Director presso Genzyme Danmark e Head-Clinical Development & Medical Affairs presso Pharmexa A. Birgitte Volck ha conseguito un dottorato presso l'Università di Copenhagen.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SOLENO THERAPEUTICS INC
0.02% | 26/05/2023 | 7 045 ( 0.02% ) | 301 526 $ | 31/03/2024 |
Posizioni attive di Birgitte Volck
| Società | Posizione | Inizio |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Director/Board Member | 10/06/2019 |
| NYKODE THERAPEUTICS | Director/Board Member | 05/05/2021 |
Precedenti posizioni note di Birgitte Volck
| Società | Posizione | Fine |
|---|---|---|
| ASCENDIS PHARMA A/S | Chief Tech/Sci/R&D Officer | 01/12/2023 |
| AVROBIO, INC. | Chief Tech/Sci/R&D Officer | 01/10/2020 |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Director/Board Member | 01/01/2020 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 01/08/2018 |
| WILSON THERAPEUTICS AB | Director/Board Member | 01/05/2018 |
Formazione di Birgitte Volck
| University of Copenhagen | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 7 |
|---|---|
| AMGEN INC. | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| NYKODE THERAPEUTICS | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| AVROBIO, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Health Technology |
TFS Trial Form Support AB
TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Commercial Services |
TFS Trial Form Support International AB
 TFS Trial Form Support International AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support International AB provides clinical contract research services. It offers clinical development planning, regulatory affairs, medical informatics, study and site coordination, clinical data management, biostatistics, medical writing, and other functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lud, Sweden. | Commercial Services |
| Genzyme Danmark | |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Birgitte Volck
